DCM
HAE icon

Dean Capital Management’s Haemonetics HAE Stock Holding History

Dean Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.37M Buy
+44,968
New +$2.89M 1.22% 20
2024
Q3 		– Sell
-8,088
Closed -$669K – 141
2024
Q2 		$669K Buy
8,088
+614
+8% +$54K 0.86% 51
2024
Q1 		$638K Buy
7,474
+3,766
+102% +$296K 0.37% 114
2023
Q4 		$317K Sell
3,708
-851
-19% -$73.6K 0.2% 119
2023
Q3 		$408K Sell
4,559
-573
-11% -$51.2K 0.31% 115
2023
Q2 		$437K Buy
5,132
+2,265
+79% +$191K 0.58% 68
2023
Q1 		$237K Sell
2,867
-302
-10% -$24.4K 0.31% 67
2022
Q4 		$249K Sell
3,169
-14
-0.4% -$1.13K 0.33% 68
2022
Q3 		$236K Sell
3,183
-2,008
-39% -$144K 0.35% 66
2022
Q2 		$338K Sell
5,191
-3,328
-39% -$197K 0.3% 72
2022
Q1 		$539K Sell
8,519
-6,790
-44% -$369K 0.47% 63
2021
Q4 		$812K Buy
15,309
+2,982
+24% +$182K 0.7% 54
2021
Q3 		$870K Sell
12,327
-1,364
-10% -$86.1K 0.8% 51
2021
Q2 		$912K Buy
+13,691
New +$969K 0.84% 53
2014
Q4 		– Sell
-2,235
Closed -$78K – 82
2014
Q3 		$78K Sell
2,235
-300
-12% -$10.7K 1.07% 44
2014
Q2 		$90K Buy
+2,535
New +$84.7K 1% 55

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dean Capital Management's HAE Position: Q2 2026 in Review

Dean Capital Management opened a new position in Haemonetics (HAE) in Q2 2026: 44,968 shares worth $3.37M. The stake represents 1.22% of the portfolio and ranks #20 among its holdings. This is a return to the name: Dean Capital Management previously reported a position in HAE as recently as Q2 2024.

Dean Capital Management first reported a position in HAE in Q2 2014 and has held it in 16 quarters since. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Dean Capital Management held 44,968 shares of Haemonetics worth $3.37M as of Q2 2026.
  • Haemonetics was a new Dean Capital Management position in Q2 2026.
  • Haemonetics made up 1.22% of Dean Capital Management's portfolio in Q2 2026, its #20 holding.
  • Dean Capital Management first reported a position in Haemonetics in Q2 2014 and has held it in 16 quarters since.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Dean Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.